Intelligence Platform

Patents

Browse 204 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8653033

Method for administering omega-conopeptide

Jazz Pharmaceuticals International III Limited · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652475

Inhibition of factor B, the alternative complement pathway and methods related thereto

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592453

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563618

Skin external preparation having excellent stability

KURARAY CO., LTD. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513198

Pharmaceutical formulation for reducing pain

Jazz Pharmaceuticals International III Limited · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8492407

Quaternary ammonium compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8426379

POT1 alternative splicing variants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8420620

Induced internalization of surface receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8378121

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8329141

Locoregional internal radionuclide ablation of abnormal tissues

The Board of Regents of the University of Texas System · Granted Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8304439

Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing r

POLITECHNIKA LÓDZKA · Granted Tue Nov 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8268786

Anti-cancer tocotrienol analogues and associated methods

First Tech International Limited · Granted Tue Sep 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8202891

Quaternary ammonium compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8183204

Methods and compositions for increasing skin remodeling

Summit Associates International Inc. · Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173424

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173115

Particle compositions with a pre-selected cell internalization mode

The Board of Regents of the University of Texas System · Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110564

Bile acid or bile salt fatty acid conjugates

Galmed International Limited · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7968117

Externally triggered microcapsules

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892554

Internalizing ErbB2 antibodies

The Regents of the University of California · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7892738

Pot1 alternative splicing variants

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871620

Immunoliposomes that optimize internationalization into target cells

The Regents of the University of California · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7834185

Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7795300

External preparation for skin

KURARAY CO., LTD. · Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582736

Prostate cancer specific internalizing human antibodies

The Regents of the University of California · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted